This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1997 Apr;48(4):1121-7.

doi: 10.1212/wnl.48.4.1121.

Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force

K N North¹, V Riccardi, C Samango-Sprouse, R Ferner, B Moore, E Legius, N Ratner, M B Denckla

Affiliations

PMID: 9109916
DOI: 10.1212/wnl.48.4.1121

Review

Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force

K N North et al. Neurology. 1997 Apr.

. 1997 Apr;48(4):1121-7.

doi: 10.1212/wnl.48.4.1121.

Authors

K N North¹, V Riccardi, C Samango-Sprouse, R Ferner, B Moore, E Legius, N Ratner, M B Denckla

Affiliation

¹ Royal Alexandra Hospital for Children, Sydney, Australia.

PMID: 9109916
DOI: 10.1212/wnl.48.4.1121

No abstract available

PubMed Disclaimer

Similar articles

Neurofibromatosis type 1: new insights into neurocognitive issues.
Acosta MT, Gioia GA, Silva AJ. Acosta MT, et al. Curr Neurol Neurosci Rep. 2006 Mar;6(2):136-43. doi: 10.1007/s11910-996-0036-5. Curr Neurol Neurosci Rep. 2006. PMID: 16522267 Review.
The impact of ADHD on the cognitive and academic functioning of children with NF1.
Pride NA, Payne JM, North KN. Pride NA, et al. Dev Neuropsychol. 2012;37(7):590-600. doi: 10.1080/87565641.2012.695831. Dev Neuropsychol. 2012. PMID: 23066937
Neurocognitive dysfunction in children with neurofibromatosis type 1.
Rosser TL, Packer RJ. Rosser TL, et al. Curr Neurol Neurosci Rep. 2003 Mar;3(2):129-36. doi: 10.1007/s11910-003-0064-3. Curr Neurol Neurosci Rep. 2003. PMID: 12583841 Review.
Neurocognitive deficits in children with neurofibromatosis type 1.
Packer RJ. Packer RJ. Curr Neurol Neurosci Rep. 2006 Mar;6(2):119-20. doi: 10.1007/s11910-996-0033-8. Curr Neurol Neurosci Rep. 2006. PMID: 16522264 No abstract available.
Impact of neurofibromatosis type 1 on school performance.
Krab LC, Aarsen FK, de Goede-Bolder A, Catsman-Berrevoets CE, Arts WF, Moll HA, Elgersma Y. Krab LC, et al. J Child Neurol. 2008 Sep;23(9):1002-10. doi: 10.1177/0883073808316366. J Child Neurol. 2008. PMID: 18827266

See all similar articles

Cited by

Alterations in white matter microstructure in neurofibromatosis-1.
Karlsgodt KH, Rosser T, Lutkenhoff ES, Cannon TD, Silva A, Bearden CE. Karlsgodt KH, et al. PLoS One. 2012;7(10):e47854. doi: 10.1371/journal.pone.0047854. Epub 2012 Oct 19. PLoS One. 2012. PMID: 23094098 Free PMC article.
Reduced cerebral arterial spin-labeled perfusion in children with neurofibromatosis type 1.
Yeom KW, Lober RM, Barnes PD, Campen CJ. Yeom KW, et al. AJNR Am J Neuroradiol. 2013 Sep;34(9):1823-8. doi: 10.3174/ajnr.A3649. Epub 2013 Jun 13. AJNR Am J Neuroradiol. 2013. PMID: 23764727 Free PMC article.
Neurofibromatosis type 1: new insights into neurocognitive issues.
Acosta MT, Gioia GA, Silva AJ. Acosta MT, et al. Curr Neurol Neurosci Rep. 2006 Mar;6(2):136-43. doi: 10.1007/s11910-996-0036-5. Curr Neurol Neurosci Rep. 2006. PMID: 16522267 Review.
A child with axillary freckling and café au lait spots.
Wainer S. Wainer S. CMAJ. 2002 Aug 6;167(3):282-3. CMAJ. 2002. PMID: 12186179 Free PMC article. No abstract available.
Cerebellar radiological abnormalities in children with neurofibromatosis type 1: part 2 - a neuroimaging natural history study with clinical correlations.
Salman MS, Hossain S, Gorun S, Alqublan L, Bunge M, Rozovsky K. Salman MS, et al. Cerebellum Ataxias. 2018 Oct 30;5:13. doi: 10.1186/s40673-018-0092-z. eCollection 2018. Cerebellum Ataxias. 2018. PMID: 30410778 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal